What occurs in individuals categorized as slow acetylators?

Individuals categorized as slow acetylators have a diminished capacity to metabolize certain drugs. This slower metabolic rate means that drugs can remain in the body for an extended period, leading to higher concentrations of these substances in the bloodstream over time.

Slow acetylation affects the liver's ability to break down and eliminate medications that are metabolized through acetylation processes. As a result, individuals in this category may have prolonged exposure to the active form of the drug, which can enhance therapeutic effects but may also increase the risk of toxicity or adverse effects due to higher blood levels. Understanding this metabolic difference is crucial for healthcare providers when prescribing medications, as it may necessitate dosage adjustments or closer monitoring for individuals identified as slow acetylators.